0001209191-17-002652.txt : 20170106 0001209191-17-002652.hdr.sgml : 20170106 20170106162839 ACCESSION NUMBER: 0001209191-17-002652 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170104 FILED AS OF DATE: 20170106 DATE AS OF CHANGE: 20170106 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Minerva Neurosciences, Inc. CENTRAL INDEX KEY: 0001598646 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 260784194 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1601 TRAPELO ROAD STREET 2: SUITE 284 CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 617-600-7373 MAIL ADDRESS: STREET 1: 1601 TRAPELO ROAD STREET 2: SUITE 284 CITY: WALTHAM STATE: MA ZIP: 02451 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Levine Mark S. CENTRAL INDEX KEY: 0001617236 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36517 FILM NUMBER: 17514577 MAIL ADDRESS: STREET 1: 1601 TRAPELO ROAD STREET 2: SUITE 284 CITY: WALTHAM STATE: MA ZIP: 02451 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-01-04 0 0001598646 Minerva Neurosciences, Inc. NERV 0001617236 Levine Mark S. C/O MINERVA NEUROSCIENCES, INC. 1601 TRAPELO ROAD, SUITE 284 WALTHAM MA 02451 0 1 0 0 SVP,General Counsel & Sec. Common Stock 2017-01-04 4 M 0 17250 4.71 A 17250 D Common Stock 2017-01-04 4 M 0 250 5.19 A 17500 D Common Stock 2017-01-04 4 S 0 17500 12.00 D 0 D Stock Option (Right to Buy) 4.71 2017-01-04 4 M 0 17250 0.00 D 2025-12-03 Common Stock 17250 51750 D Stock Option (Right to Buy) 5.19 2017-01-04 4 M 0 250 0.00 D 2025-04-13 Common Stock 250 57274 D These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 22, 2016. This option vests as follows: 25% on December 4, 2016 and then in quarterly installments over 3 years thereafter. This option vests as follows: 25% on April 14, 2016; and then in quarterly installments over 3 years thereafter. /s/ Mark Levine 2017-01-06